AxoGen Profile

28.95
USD 0.30  1.05%
100%
93%

Sale by Jamie Grooms of 43403 shares of AxoGen

AxoGen Inc insider trading alert for sale of common stock by Jamie Grooms, the corporate stakeholder, on February 16, 2018. This event was filed by Axogen Inc with SEC on 2018-02-16. Statement of changes in beneficial ownership - SEC Form 4. Jamie Grooms is currently serves as co-founder, chairman, member of audit committee and member of governance and nominating committee of AxoGen Inc [view details]   

AxoGen Summary

AxoGen Inc (AXGN) is traded on Nasdaq Capital Markets in USA. It is located in FLORIDA, U.S.A and employs 138 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 934.17 M. AxoGen Inc conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 34.09 M outstanding shares of which 975.73 K shares are presently shorted by private and institutional investors with about 4.01 trading days to cover. AXOGEN INC currently holds about 22.04 M in cash with (9.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.66.
Check AxoGen Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected AxoGen Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AxoGen Against Markets

Risk Adjusted
Performance Score (0 to 100)
2 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for AxoGen Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen operates under Medical Appliances Equipment classification in USA and traded on Nasdaq Capital Markets exchange. It employs 138 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameAxoGen Inc
CEO and President and DirectorKaren ZaderejAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationFLORIDA, U.S.A
Business Address13631 Progress Boulevard
ExchangeNasdaq Capital Markets
CIK Number00805928.0
CUSIP05463X106
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.axogeninc.com
Contact Number386 462 6800
CurrencyUSD - US Dollar

Recommendations

AxoGen Analyst Recommendations
Target PriceAdvice# of Analysts
8.92Buy3Odds
AxoGen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AxoGen Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

AxoGen Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.1February 22, 2017
AxoGen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

AxoGen Corporate Directors
Robert Rudelius Independent Director
Amy Wendell Director
Joseph Mandato Independent Director